We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-0.27%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.92B
AUM Growth
+$75.1M
Cap. Flow
+$135M
Cap. Flow %
3.46%
Top 10 Hldgs %
32.39%
Holding
6,700
New
1,026
Increased
2,252
Reduced
2,490
Closed
691

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$342M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$83.1M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$43.8M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$40.2M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$26.6M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$19.9M
2
SOXX icon
iShares Semiconductor ETF
SOXX
+$19M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$18.2M
4
CRM icon
Salesforce
CRM
+$16.1M
5
TSLA icon
Tesla
TSLA
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 18.5%
2 Consumer Discretionary 8.04%
3 Healthcare 7.14%
4 Communication Services 6.4%
5 Financials 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HFBL icon
3976
Home Federal Bancorp
HFBL
$73M
$15K ﹤0.01%
786
-46
-6% -$861
IDT icon
3977
IDT Corp
IDT
$1.67B
$15K ﹤0.01%
360
-1,915
-84% -$89.4K
IMUX icon
3978
Immunic
IMUX
$226M
$15K ﹤0.01%
175
-1,482
-89% -$146K
IPSC icon
3979
Century Therapeutics
IPSC
$349M
$15K ﹤0.01%
+597
New +$16.2K
IRIX icon
3980
IRIDEX
IRIX
$14.3M
$15K ﹤0.01%
1,958
-1,075
-35% -$7.54K
ITOS
3981
DELISTED
iTeos Therapeutics
ITOS
$15K ﹤0.01%
563
-661
-54% -$17.3K
KALV
3982
DELISTED
KalVista Pharmaceuticals
KALV
$15K ﹤0.01%
865
-5,736
-87% -$116K
LEGN icon
3983
Legend Biotech
LEGN
$3.93B
$15K ﹤0.01%
292
-229
-44% -$9.53K
MMI icon
3984
Marcus & Millichap
MMI
$1.2B
$15K ﹤0.01%
370
-1,157
-76% -$44.9K
MQ icon
3985
Marqeta
MQ
$1.71B
$15K ﹤0.01%
168
-1,540
-90% -$165K
MSGS icon
3986
Madison Square Garden
MSGS
$9.94B
$15K ﹤0.01%
83
-2,183
-96% -$374K
NAII icon
3987
Natural Alternatives International
NAII
$13.6M
$15K ﹤0.01%
1,112
+898
+420% +$14.9K
NEON icon
3988
Neonode
NEON
$14.8M
$15K ﹤0.01%
+1,478
New +$8.85K
NODK icon
3989
NI Holdings
NODK
$313M
$15K ﹤0.01%
842
-315
-27% -$6.03K
OCCI
3990
OFS Credit Co
OCCI
$77.5M
$15K ﹤0.01%
1,201
+1,141
+1,902% +$14.3K
ORMP icon
3991
Oramed Pharmaceuticals
ORMP
$182M
$15K ﹤0.01%
696
-2,397
-77% -$40.8K
PPTA
3992
Perpetua Resources
PPTA
$3.1B
$15K ﹤0.01%
3,048
+2,749
+919% +$15.3K
RPID icon
3993
Rapid Micro Biosystems
RPID
$85.3M
$15K ﹤0.01%
+789
New +$16.3K
SAR icon
3994
Saratoga Investment
SAR
$314M
$15K ﹤0.01%
+533
New +$14.7K
SES icon
3995
SES AI
SES
$227M
$15K ﹤0.01%
+1,522
New +$15.1K
SLGL icon
3996
Sol-Gel Technologies
SLGL
$275M
$15K ﹤0.01%
+150
New +$15.7K
SONY icon
3997
Sony
SONY
$138B
$15K ﹤0.01%
680
-820
-55% -$17.2K
SPWH icon
3998
Sportsman's Warehouse
SPWH
$46.8M
$15K ﹤0.01%
846
-922
-52% -$16.3K
TFSL icon
3999
TFS Financial
TFSL
$4.93B
$15K ﹤0.01%
765
-3,388
-82% -$66.1K
TSHA icon
4000
Taysha Gene Therapies
TSHA
$1.92B
$15K ﹤0.01%
790
-186
-19% -$3.54K
158 159
160
161 162

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2021 Portfolio in Review

As of Q3 2021, Tower Research Capital (TRC) held 6,700 positions worth $3.92B, up 2% from $3.84B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) deployed $135M of net new capital in Q3 2021, opening 1,026 new positions and adding to 2,252 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $19.9M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2021 buy was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $342M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2021 reduction was UnitedHealth, cutting an estimated $19.9M.
  • Tower Research Capital (TRC) fully exited iShares Semiconductor ETF in Q3 2021, selling an estimated $19M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.92B portfolio in Q3 2021.
  • Tower Research Capital (TRC) opened 1,026 new positions and closed 691 in Q3 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 2% quarter-over-quarter to $3.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.